Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/42913
Title: | Taxane-induced scleroderma. Report of two cases |
Authors: | CURY-MARTINS, Jade; GIESEN, Laura; GONZÁLEZ, Sergio; MOLGO, Montserrat; SANCHES, Jose Antonio |
Citation: | REVISTA MéDICA DE CHILE, v.149, n.5, p.807-809, 2021 |
Abstract: | ABSTRACT Taxanes are a class of chemotherapeutic agents with common associated dermatologic adverse events, such as skin hyperpigmentation, hand-foot skin syndrome, paronychia and onycholysis. Taxane-induced scleroderma is rare. Few cases with skin findings resembling systemic sclerosis, have been reported after the administration of these agents. We report two cases with stage IV breast cancer, aged 66 and 71 years, who developed sclerodermic skin lesions in their extremities after starting treatment with placlitaxel and nabplaclitaxel respectively. Los taxanos son agentes quimioterapéuticos cuyo uso se asocia a problemas dermatológicos tales como hiperpigmentación, síndrome manos-pies, paroniquia y onicolisis. La esclerodermia inducida por taxanos es rara, con pocos casos informados en la literatura. Informamos los casos de dos pacientes con cáncer de mama en estado IV, de 66 y 71 años, que desarrollaron lesiones esclerodérmicas en las extremidades después de ser tratadas con placlitaxel y nabplaclitaxel, respectivamente. |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MDT Artigos e Materiais de Revistas Científicas - HC/ICESP Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - LIM/53 Artigos e Materiais de Revistas Científicas - LIM/56 Artigos e Materiais de Revistas Científicas - ODS/03 Artigos e Materiais de Revistas Científicas - ODS/10 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_GIESEN_Taxaneinduced_scleroderma_Report_of_two_cases_2021.PDF | publishedVersion (English) | 826.23 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.